ليتروزول تيڤع

Nchi: Israeli

Lugha: Kiarabu

Chanzo: Ministry of Health

Viambatanisho vya kazi:

LETROZOLE 2.5 MG

Inapatikana kutoka:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kanuni:

L02BG04

Dawa fomu:

TABLETS

Njia ya uendeshaji:

PER OS

Viwandani na:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Kundi la matibabu:

LETROZOLE

Matibabu dalili:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Idhini ya tarehe:

2010-01-01